Büyükdoğan Halil, Ertürk Cemil, Eren Erdal, Öztürk Çiğdem, Yıldırım Burak, Sarıtaş Tahir Burak, Demirkol Metehan
Istanbul Kanuni Sultan Süleyman Training and Research Hospital, Department of Orthopaedics and Traumatology, Health Sciences University, Istanbul, Turkey.
Gülhane Training and Research Hospital, Department of Orthopaedics and Traumatology, Health Sciences University, Ankara, Turkey.
Connect Tissue Res. 2025 May;66(3):161-174. doi: 10.1080/03008207.2025.2479501. Epub 2025 Mar 22.
This study aimed to evaluate the early effects of N-acetylcysteine, which has antioxidant, inflame-modulatory, and cytoprotective properties, on tendon healing.
Thirty-five male Wistar Hannover rats were divided into five groups: first-week treatment (Group 1T), first-week control (Group 1C), third-week treatment (Group 3T), third-week control (Group 3C), and native tendons (Group N). Bilateral Achilles tenotomy was performed on all rats except Group N. After tenotomy, 150 mg/kg N-acetylcysteine was administered daily intraperitoneally to treatment groups, while isotonic saline was given to the control groups. Tendons were evaluated histopathologically, immunohistochemically, and biomechanically after sacrifice in the first and third weeks.
No significant differences were observed in the first week ( > 0.05). Movin and Bonar scores (lower scores reflect improved histologic healing) were significantly lower in Group 3T than in Group 3C ( = 0.002). Collagen type-I/type-III ratios were higher in Group 3T compared to Group 3C ( = 0.001). Fmax (N) values were similar across Group 3T, Group 3C, and Group N ( = 0.772). However, cross-sectional areas (mm) were significantly smaller in Group 3T than in Group 3C ( = 0.001), with the smallest areas observed in native tendons. Thus, tensile strength (MPa, load per unit area) and toughness (J/10 mm, energy absorbed per unit volume) were significantly higher in Group 3T than in Group 3C ( = 0.001).
N-acetylcysteine supplied some improved results on early markers of tendon healing. Although our findings support the potential of NAC as a therapeutic adjunct in tendon injuries, further studies are needed to evaluate the long-term effects and underlying mechanisms.
本研究旨在评估具有抗氧化、炎症调节和细胞保护特性的N-乙酰半胱氨酸对肌腱愈合的早期影响。
35只雄性Wistar Hannover大鼠分为五组:第一周治疗组(1T组)、第一周对照组(1C组)、第三周治疗组(3T组)、第三周对照组(3C组)和正常肌腱组(N组)。除N组外,对所有大鼠进行双侧跟腱切断术。切断术后,治疗组每天腹腔注射150mg/kg N-乙酰半胱氨酸,对照组注射等渗盐水。在第一周和第三周处死大鼠后,对肌腱进行组织病理学、免疫组织化学和生物力学评估。
第一周未观察到显著差异(>0.05)。3T组的Movin和Bonar评分(分数越低表明组织学愈合越好)显著低于3C组(=0.002)。与3C组相比,3T组的I型/III型胶原比率更高(=0.001)。3T组、3C组和N组的最大力(N)值相似(=0.772)。然而,3T组的横截面积(mm)显著小于3C组(=0.001),正常肌腱的横截面积最小。因此,3T组的拉伸强度(MPa,单位面积负荷)和韧性(J/10mm,单位体积吸收的能量)显著高于3C组(=0.001)。
N-乙酰半胱氨酸在肌腱愈合的早期指标方面提供了一些改善结果。尽管我们的研究结果支持NAC作为肌腱损伤治疗辅助药物的潜力,但仍需要进一步研究来评估其长期影响和潜在机制。